The symposium will take place November 3-4 on the UW Medicine South Lake Union campus and will feature keynote addresses from ISCRM Associate Director Jen Davis, PhD and David Granville, PhD, Professor and Associate Dean Research, Faculty of Medicine, University of British Columbia. Read More
The Musculoskeletal Systems Biology Lab (MSBL), directed by ISCRM faculty member Ron Kwon, has received a $431,765 award from the NIH in recognition of excellence in DEIA (diversity, equity, inclusion, and accessibility) mentorship. Read More
A study from the Musculoskeletal Systems Biology Lab sheds a light on the characteristics of zebrafish cells that are able to differentiate from progenitor cells into bone cells, and then revert back to a progenitor state. Read More
A team of investigators led by ISCRM faculty members David Mack, PhD and Nate Sniadecki, PhD have shown that is possible to recreate DMD with much more complexity in a 3D model of engineered heart tissue. Read More
State-funded ISCRM Fellowships enable students at the undergraduate, graduate, and postdoctoral level to advance research efforts aimed at addressing the root causes of diseases. Read More
Thelma Escobar, PhD is collaborating with the Doulatov Lab and the Stem Cell Core to study how mutations in the gene NPM1 drive AML onset. Read More
ISCRM faculty member Patrick Boyle has received a five-year, $2.9 million grant from the National Heart, Lung, and Blood Institute to improve outcomes for stroke patients by identifying and testing individualized strategies for diagnosing and treating strokes. Read More
In the Freedman Lab, knocking out primary cilia reveals insights about the role the organelles play in cell fate and disease development. Read More
Using gene-editing tools to decrease expression of lamin B1 in two stem cell models, the researchers show that deletion of lamin B1 causes change in stem cell function and nuclear shape – and contributes to leukemia progression. Read More
ISCRM researchers have developed a tool to selectively control the PRC2 complex – an epigenetic regulator that influences cell fate across multiple stages of development. That tool is a computer-designed protein binder engineered in partnership with the Institute for Protein Design (IPD). Read More